Transient Ischemic Attack
177
18
27
98
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
17 trials with published results (10%)
Research Maturity
98 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.5%
8 terminated out of 177 trials
92.5%
+5.9% vs benchmark
10%
18 trials in Phase 3/4
17%
17 of 98 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 98 completed trials
Clinical Trials (177)
Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke
Pathophysiology and Risk of Atrial Fibrillation Detected After Ischemic Stroke
Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Florbetaben for Imaging of Vascular Amyloid
Florida Cerebrovascular Disease Biorepository and Genomics Center
A Novel Rural Integrated Care and Early Prevention Model for Older Adults at High Risk of or Living With Stroke in China
Stroke-Card Registry
Comparison Between Non-contrast Magnetic Resonance Angiography and Carotid Doppler in Cerebrovascular Stroke
Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or Transient
Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
Smartwatch-Guided Secondary Prevention After Stroke
Imaging and Serological Biomarkers of Autonomic Dysfunction After Ischemic Stroke
Reducing Stroke Risk in African-American Men
Genotype Guided Antiplatelet Therapy In Ischemic Stroke
A Person-centred Care Transition Support for People With Stroke/TIA
Reshaping the Path of Vascular Cognitive Impairment (VCI)